Brkic, F.F.; Stoiber, S.; Maier, T.; Gurnhofer, E.; Kenner, L.; Heiduschka, G.; Kadletz-Wanke, L.
Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma. Pharmaceuticals 2022, 15, 378.
https://doi.org/10.3390/ph15030378
AMA Style
Brkic FF, Stoiber S, Maier T, Gurnhofer E, Kenner L, Heiduschka G, Kadletz-Wanke L.
Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma. Pharmaceuticals. 2022; 15(3):378.
https://doi.org/10.3390/ph15030378
Chicago/Turabian Style
Brkic, Faris F., Stefan Stoiber, Tobias Maier, Elisabeth Gurnhofer, Lukas Kenner, Gregor Heiduschka, and Lorenz Kadletz-Wanke.
2022. "Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma" Pharmaceuticals 15, no. 3: 378.
https://doi.org/10.3390/ph15030378
APA Style
Brkic, F. F., Stoiber, S., Maier, T., Gurnhofer, E., Kenner, L., Heiduschka, G., & Kadletz-Wanke, L.
(2022). Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma. Pharmaceuticals, 15(3), 378.
https://doi.org/10.3390/ph15030378